Corton Capital Inc. Pliant Therapeutics, Inc. Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $49,778 - $73,445	4,705 Added 41.67%	15,996 $171,000
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $102,613 - $142,164	-7,257 Reduced 39.13%	11,291 $168,000
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $92,635 - $138,052	7,209 Added 63.58%	18,548 $335,000
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $165,322 - $228,480	11,339 New	11,339 $196,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $64,720 - $137,786	15,747 New	15,747 $126,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.